EXPANDING REMDESIVIR’S THERAPEUTIC SPECTRUM FROM ANTIVIRAL PROPERTIES TO ANTICANCER ACTIVITY THROUGH MTOR INHIBITION
Zeynep Büşra Aksoy, Gökçe Yağmur Summak, Mehmet Altay Ünal, AÇELYA YILMAZER AKTUNA et autres
Objective: The dysregulation of the mammalian target of rapamycin (mTOR) pathway is a prominent feature of various cancers, rendering it an attractive target for therapeutic intervention. While some mTOR inhibitors have been employed in cancer treatment, their use is often associated with …
tr, pa (code pays fourni par la source)
0 citations
Ankara Universitesi Eczacilik Fakultesi Dergisi